Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario
Sharifa Nasreen, Hannah Chung, Siyi He, et al.
Nature Microbiology (2022) Vol. 7, Iss. 3, pp. 379-385
Open Access | Times Cited: 231

Showing 1-25 of 231 citing articles:

Intramuscular AZD7442 (Tixagevimab–Cilgavimab) for Prevention of Covid-19
Myron J. Levin, Andrew Ustianowski, Stéphane De Wit, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 23, pp. 2188-2200
Open Access | Times Cited: 614
COVID-19 vaccine development: milestones, lessons and prospects
Maochen Li, Han Wang, Lili Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 331
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis
Baoqi Zeng, Le Gao, Qingxin Zhou, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 234
Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications
Fen Zhang, Raphaela Iris Lau, Qin Liu, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 20, Iss. 5, pp. 323-337
Open Access | Times Cited: 177
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
Gary R. McLean, Jeremy P. Kamil, Benhur Lee, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 174
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Wei-Yu Chi, Yen-Der Li, Hsin‐Che Huang, et al.
Journal of Biomedical Science (2022) Vol. 29, Iss. 1
Open Access | Times Cited: 166
Effect of COVID-19 Vaccines on Reducing the Risk of Long COVID in the Real World: A Systematic Review and Meta-Analysis
Peng Gao, Jue Liu, Min Liu
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 19, pp. 12422-12422
Open Access | Times Cited: 152
The effectiveness of COVID-19 vaccines in reducing the incidence, hospitalization, and mortality from COVID-19: A systematic review and meta-analysis
Kazem Rahmani, Rasoul Shavaleh, Mahtab Forouhi, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 151
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
Two Years into the COVID-19 Pandemic: Lessons Learned
Severino Jefferson Ribeiro da Silva, Jéssica Catarine Frutuoso do Nascimento, Renata Pessôa Germano Mendes, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 9, pp. 1758-1814
Open Access | Times Cited: 103
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study
Marit J. van Gils, A. H. Ayesha Lavell, Karlijn van der Straten, et al.
PLoS Medicine (2022) Vol. 19, Iss. 5, pp. e1003991-e1003991
Open Access | Times Cited: 93
Adaptive Immune Responses and Immunity to SARS-CoV-2
Dragan Primorac, Kristijan Vrdoljak, Petar Brlek, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 88
Effectiveness of inactivated and Ad5-nCoV COVID-19 vaccines against SARS-CoV-2 Omicron BA. 2 variant infection, severe illness, and death
Zhuoying Huang, Shuangfei Xu, Jiechen Liu, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 81
Update on the effectiveness of COVID-19 vaccines on different variants of SARS-CoV-2
Negar Firouzabadi, Parisa Ghasemiyeh, Fatemeh Moradishooli, et al.
International Immunopharmacology (2023) Vol. 117, pp. 109968-109968
Open Access | Times Cited: 74
Role of COVID-19 Vaccines in SARS-CoV-2 Variants
Zhou Zhou, Yimiao Zhu, Ming Chu
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 73
AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery
Yue Xu, Shihao Ma, Haotian Cui, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 15
Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice
Rúbens Prince dos Santos Alves, Julia Timis, Robyn Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
An Update on Anti-COVID-19 Vaccines and the Challenges to Protect Against New SARS-CoV-2 Variants
Fábio Mambelli, Ana Carolina V. S. C. de Araujo, Jéssica Pires Farias, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 23-23
Open Access | Times Cited: 1
COVID-19 vaccine strategies must focus on severe disease and global equity
Peter McIntyre, Rakesh Aggarwal, Ilesh Jani, et al.
The Lancet (2021) Vol. 399, Iss. 10322, pp. 406-410
Open Access | Times Cited: 78
Bioactive natural products in COVID-19 therapy
Zhonglei Wang, Ning Wang, Liyan Yang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 56
Covid-19: virology, variants, and vaccines
Megan Young, Harry Crook, J. T. Scott, et al.
BMJ Medicine (2022) Vol. 1, Iss. 1, pp. e000040-e000040
Open Access | Times Cited: 43
SARS-CoV-2: phenotype, genotype, and characterization of different variants
Mohammadreza Saberiyan, Elham Karimi, Zahra Khademi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 40
Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance
Lirong Cao, Jingzhi Lou, See Yeung Chan, et al.
Nature Medicine (2022) Vol. 28, Iss. 8, pp. 1715-1722
Open Access | Times Cited: 39
Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes among individuals with immune-mediated inflammatory diseases tested between March 1 and Nov 22, 2021, in Ontario, Canada: a population-based analysis
Jessica Widdifield, Jeffrey C. Kwong, Simon Chen, et al.
The Lancet Rheumatology (2022) Vol. 4, Iss. 6, pp. e430-e440
Open Access | Times Cited: 38
Development and applications of mRNA treatment based on lipid nanoparticles
Zhe Wang, Wanting Ma, Xingxing Fu, et al.
Biotechnology Advances (2023) Vol. 65, pp. 108130-108130
Closed Access | Times Cited: 29
Page 1 - Next Page

Scroll to top